Ash serves as Head of Research at Mercia Technologies, where his team delivers data-driven insights to support investment and strategic decision-making. He is also an active investor focusing on early and growth-stage healthcare, biotech and life science companies.
Prior to joining Mercia, Ash was the clinical technology director at Babylon Health where he helped to build a multi-award winning medical technology platform which secured Europe's largest ever Series A investment in digital health ($25.0million). Ash is also an anaesthetics and critical care doctor having trained at the Imperial School of Anaesthesia. He holds an MA and Medical Degree from the University of Oxford, and is a member of the CFA Institute, London.